What do the upcoming trends in medical devices look like? In the fast-changing healthcare sector, keeping up-to-date with the newest developments in medical technology is crucial for experts and enthusiasts. Medical Device News Magazine is a crucial source of information, providing valuable perspectives on state-of-the-art innovations, regulatory changes, FDA updates on medical devices, and industry trends affecting patient care and business approaches. Our goal is to connect healthcare professionals, investors, and the medical device industry by offering breaking medical device news and articles authored by experts in this space. Medical Device News Magazine aims to stimulate discussions on advancements in medical devices and biotechnology, and their impact on the future of medicine.
The new RED 72 SILVER LABEL with SENDit® Technology has shown a remarkable 50% increase in trackability over the original RED 72 with SENDit Technology.
Phasix™ ST Umbilical Hernia Patch leverages same surgical technique as permanent mesh procedures
The trial evaluates R3 Vascular’s next-generation drug-eluting bioresorbable scaffold, MAGNITUDE®, for below-the-knee (BTK) PAD, which according to the American Heart Association affects more than 200 million people globally, and 10 to 12 million in the U.S. older than the age of 40. The most common type of PAD affects the lower-extremity where blood flow is reduced to the legs and feet. Each year, approximately 150,000 leg amputations are performed in the U.S. alone.
Discover how at-home diagnostics are transforming the detection of undiagnosed sleep apnea and enabling essential treatments.
“RGX-202 is the only next generation gene therapy for Duchenne in a pivotal phase trial. The new data from the age 1-3 cohort builds on the favorable safety and efficacy profile seen in ages 4 and older and reinforces the potential of RGX-202 to serve a wide age range of patients,” said Steve Pakola, M.D., Chief Medical Officer of REGENXBIO.
Published online March 19 in the journal Nature, the study mapped the activity of a group of nerve cells in the bird’s brain called the central nucleus of the anterior arcopallium (AAC), which is known to strongly influence the muscles in its vocal organ. Different groups of AAC cells were found to produce sounds akin to consonants and vowels.
Vidofludimus Calcium’s Activation of Nurr1 reduces neuronal loss and injury directly and Indirectly by decreasing microglial activations in preclinical models.
The presentation is scheduled for April 23, 2025, at 12:25 PM ET, Room 206 at the Walter E. Washington Convention Center, Washington, D.C.
During the presentation, Mr. Emalfarb will provide an overview of recent preclinical research utilizing Dyadic’s proprietary C1 expression platform, including data related to the production of non-mRNA antigens and reagents for vaccine production.
The Octave MSDA Test is being used by leading MS Centers of Excellence, academic institutions, and independent neurology practices across the United States, providing clinicians with critical biomarker-driven insights to support treatment decisions.
This raise reflects accelerating market conviction that healthcare advocacy is a critical standard of care that drives better outcomes, lowers costs, and enhances patient experiences notes Solace.
The investment will support further development of TRIMTECH Therapeutics growing pipeline of potent, CNS (central nervous system) penetrant therapeutics based on its aggregate-selective degrader molecules known as TRIMTACs. The pipeline is focused around the development of treatments for severe neurodegenerative and inflammatory disorders, including Alzheimer’s and Huntington’s disease.
The oversubscribed round was led by new investor HealthQuest Capital with support from existing OrganOx investors BGF and Lauxera Capital Partners, along with additional new investors Sofina, Soleus Capital, and Avidity Partners.
Executives On The Move
Dr. Uspenskaya-Cadoz brings two decades of experience in neurology, gene therapy, and clinical development, enhancing VectorY’s leadership in developing transformative treatments for neurodegenerative conditions.
In this role, Dr Martin Hepburn will drive Panther’s strategic commitment to commercialize its patented MAP technology, with a primary focus on reducing time-to-market and delivering the first commercial product to customers within the next two years.
Michael Andersen brings more than 20 years of commercial leadership experience in electrophysiology and medtech, with a strong track record of market development, sales execution, and strategic growth.
“I am honored to lead Nimbus at this pivotal time in the company’s evolution,” said Abbas Kazimi. “Our robust pipeline, anchored by promising programs like our WRN and SIK inhibitors, and our ongoing collaboration with Lilly, continues to validate our approach and strengthen our position in the industry. I’m particularly excited about what Nimbus will continue to discover and advance, as we leverage our computational drug discovery engine to bring innovative medicines for patients.”
This partnership immediately positions NeuralCure AI for rapid, real-world application, further solidifying its role as a pioneer in AI-powered healthcare solutions. Unlike traditional AI models that provide generalized insights, NeuralCure AI creates patient-specific digital twins and runs constant treatment simulations, helping physicians make more informed, data-driven decisions without replacing clinical judgment.
Discover how Philips and Mass General Brigham are transforming healthcare with innovative AI solutions for better patient outcomes.
“We have maintained an advisory relationship with Kewaunee for many years and are proud to have played a role in the successful strategic acquisition of Nu Aire by Kewaunee,” added Evan Tomaskovic, Managing Partner at Carl Marks Advisors. “It is gratifying to assist a 100-year-old business complete a key acquisition of a more than 50-year-old family-owned business, fortifying the legacies of both world-class organizations.”
With the acquisition complete, ZOLL will immediately make available to customers the bellavista®, fabian®*, LTV®, and 3100 HFOV product lines alongside ZOLL’s other respiratory care offerings. For these acquired product lines, all ventilators and associated consumables, service parts, accessories, and service program offerings will continue to be sold where currently available. Existing Vyaire contact channels will remain available for use during a transition period. Customers can also contact ZOLL at ventsales@zoll.com.
Pam Health advises the new hospital will create approximately 80 new jobs including medical professional and support staff positions.
The Business of Healthcare
The healthcare industry has seen significant changes and transformations in the rapidly advancing world of technology. One of the most groundbreaking developments in recent times
Tips for Healthcare Professionals
Running a med spa is a lucrative way to make people look and feel better, but like everything else, it has significant risks.
Healthcare Careers
Becoming a doctor is a long and difficult process that requires many years of schooling and training. But for those passionate about helping others, it can be the most rewarding career imaginable. Many pathways can lead to becoming a doctor, but all require hard work and dedication.
ACEP proposes that CMS update its emergency services Condition of Participation (CoP) with a requirement for hospitals to have a plan in place, and to act on it, when the number of patients boarding in the emergency department for hours, days, or longer until a staffed inpatient bed becomes available exceeds a particular threshold.
The study’s results were published today in Radiology, a journal of the Radiological Society of North America (RSNA).
In the world of advanced practice nursing, a nurse practitioner (NP) role allows you to specialize in an area like pediatrics, women’s health, or adult geriatrics.
Prominent writing skills are crucial for any scientific industry, particularly for future nursing experts who should establish trusting communication with patients and colleagues. Good writing
Copyright 2025 | All Rights Reserved | Medical Device News Magazine, is a Division of PTM Healthcare Marketing, Inc.
